AzTrials
AzTrials

Normal Pressure HydrocephalusNPHNCT06426004

Addressing Health Disparities in Normal Pressure Hydrocephalus (NPH) in Maryland

A study testing patients will receive NPH education, primary care physicians (PCPs) will receive professional NPH education and A community health worker will assist PCP in people with Normal Pressure Hydrocephalus and Hakim Syndrome, run by Johns Hopkins Bloomberg School of Public Health at 2 sites in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The study aims to estimate Normal Pressure Hydrocephalus (NPH) prevalence and evaluate health equity gaps in Baltimore and Maryland based on zip codes and race, with a focus on the Black community. Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
Conditions the study is for
Normal Pressure Hydrocephalus, Hakim Syndrome
What is being tested?
patients will receive NPH education, primary care physicians (PCPs) will receive professional NPH education and A community health worker will assist PCP
Could I receive a placebo?
No, everyone receives an active treatment
How many people
660 participants
Where
2 sitesUnited States
Study dates
1 Aug 2027to 30 Mar 2032
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • People over 65 years old who have completed the Annual Wellness Survey (AWV) survey
  • have a clinical profile in the Hopkins Epic data sets
  • live in Maryland

Who cannot join

  • People under 65 years old will be excluded if they have not completed the AWV survey
  • do not live in Maryland
  • Community Health Worker (CHW) Inclusion Criteria:
  • certified Community Health Workers from Maryland
  • completed accredited training by the Maryland Department of Health
  • Primary Care Physician inclusion criteria:
  • must have patients in Johns Hopkins University AWV

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Hossein Zare, MS, PhD contact

4106147246

hzare1@jhu.edu

Mark G Luciano, PhD, FACS contact

markluciano@jhu.edu

United States2 sites
  • Johns Hopkins University and Hospital

    Baltimore, Maryland, 21205

    Hossein Zare, MS, PhD, 410-614-7246, hzare1@jhu.edu

    Mark G Luciano, PhD, FACS, markluciano@jhu.edu

  • Johns Hopkins University

    Baltimore, Maryland, 21205

Other trials in United States

About this study

Official title: Community Interventions to Address Health Disparities in the Care of Normal Pressure Hydrocephalus (NPH) in Maryland

The study aims to estimate Normal Pressure Hydrocephalus (NPH) prevalence and evaluate health equity gaps in Baltimore and Maryland based on zip codes and race, with a focus on the Black community. Interventions will include educational elements about NPH and three layers targeting patients, Primary Care Providers, and community health workers to enhance care access. Short-term outcomes will measure referrals to specialists, while long-term outcomes will assess healthcare utilization. The study aims to identify and reduce racial disparities in NPH care access, informing intervention strategies for NPH and other surgical areas.

Read the detailed description

This proposal responds to an established need for developing an evidence-based and community-informed approach to address health disparities in specialty surgical clinics where barriers to accessing care are multiplied along each level of the referral pathway. The study will focus on Normal Pressure Hydrocephalus (NPH) related care - a clinical syndrome characterized excess cerebrospinal fluid (CSF) in the brain resulting in symptoms of falls, dementia, and urinary incontinence, that is treated surgically by shunting to remove excess fluid from the brain. This disorder afflicts an estimated about 750,000 Americans, and prevalence increases with age. Limited information regarding racial and socioeconomic contributing factors associated with diagnosis and treatment is available.

Studies show NPH goes underdiagnosed in the USA. In the first part of the study the investigators will estimate NPH prevalence, the health equity gap in Baltimore and greater Maryland (MD), the health equity gap based on Zip Code as a marker of sociodemographic community status, and the health equity gap based on race, looking at the Black community, which comprises over 60% of the Baltimore and 30% in MD population. In the second part of the study, the investigators will develop three layers of interventions that involve educational elements about NPH and evaluate which provides the most benefit including referrals to NPH related care. 1) Patients identified from the first part of the study with possible NPH symptoms will receive intervention 2) Patients, and the Primary Care Providers (PCPs) receive intervention, and 3) patients, and PCP receive intervention and with additional community health workers (CHWs) assisting providers with managing the patient care including referrals, addressing socioeconomic barriers, transportation to receive care.

The success of these interventions will be evaluated by short-term outcomes such as referrals to specialists including neurologists and neurosurgeons every 6 months, and long-term outcomes such as healthcare utilization including screening for shunt surgery within 12 months. This study aims to identify racial disparities in access to NPH care and intervention outcomes will evaluate the effect of different interventions on reducing racial disparities and to help developing a referral system to address the needs of most vulnerable population and Zip Codes in Baltimore and greater MD. Using the results of this study will help to identify gaps, understand the best intervention, and develop intervention strategies not only for NPH but potentially other surgical areas.

Being tested
patients will receive NPH education, primary care physicians (PCPs) will receive professional NPH education, A community health worker will assist PCP
Medical subject headings
Hydrocephalus, Normal Pressure

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • patients will receive NPH educationOther

    Patients will benefit from the Hydrocephalus Association's (HA) educational strategy for idiopathic normal pressure hydrocephalus (iNPH) emphasizes patient collaboration in the development of educational materials specifically for this condition. HA has a library of assets that include PowerPoint presentations, videos, and online and print educational materials. There will be also in-person outreach resulting recruitment, website (the study website and HA website), webform (with a symptom of gait, dementia, and bladder symptoms), YouTube videos. The investigators will also go to the communities like senior centers, health fair, and churches, then we will give a talk about iNPH. These resources will be carefully adjusted to suit low-income demographics, guided by feedback from Baltimore audiences and HA's iNPH volunteers.

  • primary care physicians (PCPs) will receive professional NPH educationOther

    A comprehensive professional development program for PCPs and CHWs, featuring presentations, educational videos, webinars, and tools on iNPH diagnosis, treatment, and care management. Provider Continuing Medical Education (CME) credits will be offered for in-person lectures, aiming to equip PCPs with the skills needed to address iNPH in low-income settings effectively

  • A community health worker will assist PCPOther

    A community health worker will assist PCP to identify barriers and help overcome these barriers in order for patient to access iNPH care.

Study groups in NCT06426004
Study groupRoleWhat they receive
Patients and the patient's familyExperimentalAll patients and the patient's family will receive NPH-related education.
Receives: Other: patients will receive NPH education; Other: primary care physicians (PCPs) will receive professional NPH education; Other: A community health worker will assist PCP
PCPs TrainingExperimentalPrimary Care Provider (PCP) will receive NPH education.
Receives: Other: primary care physicians (PCPs) will receive professional NPH education; Other: A community health worker will assist PCP
CHWs assist PCPsExperimentalA community health worker (CHW) will assist PCP.
Receives: Other: A community health worker will assist PCP

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. number of referrals

    number of referrals for suspicion of NPH to neurologists or neurosurgeons

    Measured: 6 months

  2. number of screenings

    number of screenings for shunt surgery

    Measured: 12 months

  3. number of screenings

    number of screenings for shunt surgery

    Measured: 24 months

Secondary outcomes (1)
  1. number of NPH's consultations

    number of patients who have received a consultation

    Measured: 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 May 2024
  2. Study start1 Aug 2027 (estimated)
  3. Primary completion30 Sep 2027 (estimated)
  4. Study completion30 Mar 2032 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Factorial
Model description
The investigators will develop three layers of interventions that involve educational elements about NPH and evaluate which provides the most benefit including referrals to NPH related care. 1) Patients identified from the first part of the study with possible NPH symptoms will receive intervention 2) Patients, and the Primary Care Providers (PCPs) receive intervention, and 3) patients, and PCP receive intervention and with additional community health workers (CHWs) assisting providers with managing the patient care including referrals, addressing socioeconomic barriers, transportation to receive care.
Masking
None (open label)
Enrolment
660 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06426004
Sponsor's protocol ID
IRB00028028
Acronym
NPH
Status last verified
May 2026
First submitted
15 May 2024
Last updated
7 May 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The study protocol and analytic plan will be freely available. In addition to analytical files, the Stata, Statistical Analysis System (SAS), R codes and programs and data dictionary will be available to researchers approved by one of the study's Principal Investigators to receive data. All papers must include an acknowledgment section that includes the funding source.

Questions about this trial

What is this clinical trial studying?

A study testing patients will receive NPH education, primary care physicians (PCPs) will receive professional NPH education and A community health worker will assist PCP in people with Normal Pressure Hydrocephalus and Hakim Syndrome, run by Johns Hopkins Bloomberg School of Public Health at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 7 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Hossein Zare, MS, PhD (4106147246, hzare1@jhu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

number of referrals (time frame: 6 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in